Ziltivekimab Biosimilar(Anti-IL-6 / IFNb2 Reference Antibody) Datasheet DC Chemicals
Description
Ziltivekimab (COR-001) is a humanized monoclonal antibody against IL-6 that effectively reduces serum CRP levels. Ziltivekimab possesses anti-inflammatory activity and can be used in research related to chronic systemic inflammation associated with chronic kidney disease (CKD) and cardiovascular diseases such as atherosclerosis.